SHINVA Advances the Asia-Pacific Pharmaceutical Industry with Innovative Solutions at ISPE Singapore 2026

Held from August 19 to 21, 2026, the ISPE Singapore Conference and Exhibition took place at Suntec Singapore Convention and Exhibition Centre. As a professional grand event in the field of Asia-Pacific biopharmaceutical manufacturing, it gathered 2,599 industry professionals from 32 countries, bringing together equipment suppliers, pharmaceutical enterprises and engineering service providers. The exhibition serves as a core platform for regional pharmaceutical technology exchanges.

Leveraging this international platform, SHINVA displayed its core business portfolio on site, covering large and small-volume injections, sterile assurance systems, biopharmaceutical processes and integrated EPC pharmaceutical engineering solutions, fully demonstrating its one-stop comprehensive capabilities in the pharmaceutical sector.

This overseas exhibition is an important practice for SHINVA’s biopharmaceutical business to showcase its strengths to the global market. During the event, SHINVA carried out in-depth technical exchanges with global peers, further consolidating cooperative relationships with existing customers in Singapore and Southeast Asia. The team actively explored agent channel resources and strived to build overseas benchmark cases, accelerating the implementation of the company’s international strategy in Southeast Asia. SHINVA will continue to empower the high-quality development of the global pharmaceutical industry with innovative technologies.